Human IL-12p70 ELISA Kit
Product Specifications
- Catalogue N°
- 950.070.048 - 1 x 48 Discovery (pre-coated)
950.070.096 - 1 x 96 (pre-coated)
950.070.192 - 2 x 96 (pre-coated) - Assay Range
- 6.25 pg/ml - 200 pg/ml
- Sensitivity
- 2.2 pg/ml
- Target species
- Human
- Specificity
- Recognizes both natural and recombinant human IL-12. Specific to p70 heterodimer.
- Incubation
- 3h45
- Sample Type
- Serum, Plasma, Cell culture supernatant
- Sample Size
- 100 µl
- Cross Reaction
- No cross reactivity with other human cytokines
- Kit Content
- Diaclone ELISA Kits include pre-coated strip plates, biotinylated secondary antibody, standards, controls (where applicable), buffers, streptavidin-HRP, TMB, stop reagents and a detailed procedure.
- Synonym
- IL-12
References
- Belderbos, M. E. et al., Clin Immunol.,2009; 133(2): 228-37. - Pubmed link
- Bellanger, A.-P. et al.,Clin. Vaccine Immunol., 2013 ; 20(8): 1133-1142. - Pubmed link
- Boissel, N. et al., J Leukoc Biol.,2006; 79(4): 747-56. - Pubmed link
- Botella-Carretero J. I. et al., Eur. J. Endocrinol., 2005; 153(2): 223 - 230 - Pubmed link
- Charbonnier, A. S. et al., J Leukoc Biol.,2003; 73(1): 91-9. - Pubmed link
- El-Emshaty, H. M. et al.,Dis Markers 2015: 707254 - Pubmed link
- Foucher, E. D. et al.,PLoS One,2013;8(2):e56045 - Pubmed link
- Gironella J. et al., Gut, 2005; 54(9): 1244 - 1253 - Pubmed link
- Gosset P. et al., J. Immunol., 2003 ; 170(10):4943 - 4952 - Pubmed link
- Guo, Z. et al., Biomed Rep.,2016;5(5): 567-573 - Pubmed link
- Hatzfeld-Charbonnier, A. S. et al., J Leukoc Biol.,2007;81: 1179 - 1187 - Pubmed link
- Hernandez, C. et al., PLoS One,2014;9(6):e98458 - Pubmed link
- Hessle, C. et al., Infect Immun.,2000;68(6): 3581-6. - Pubmed link
- Hessle, C. et al.,Clin Exp Immunol.,1999; 116(2): 276-82 - Pubmed link
- Krispin, A. et al., Blood,2006; 108(10): 3580-9. - Pubmed link
- Lakomy, D. et al.,J. Immunol., 2011; 187: 2775 - 2782 - Pubmed link
- Lu, C. et al., Lupus, 2015;24(1):18-24 - Pubmed link
- Madej, M. et al., Reumatologia,2015; 53(1): 9-13. - Pubmed link
- Olivar, R. et al., J. Immunol.,2016;196(10): 4274-4290 - Pubmed link
- Op den Brouw, M. L. et al., Immunology,2009;126(2):280-9 - Pubmed link
- Pichavant, M. et al., J Immunol., 2006;177(9): 5912-9. - Pubmed link
- Ratajczak, C. et al., J Biomed Biotechnol., 2007(1): 71921 - Pubmed link
- Rea D. et al., Blood, 2000; 95(10): 3162 - 3167 - Pubmed link
- Rea D. et al., J. Immunol., 2001; 166(8): 5236 -5244 - Pubmed link
- Rea D. et al., J. Virol., 1999; 73(12): 10245 -10253 - Pubmed link
- Schmitt, C. et al., J Leukoc Biol.,2000; 68(6): 836-44. - Pubmed link
- Sene, D. et al.,PLoS Pathog.,2010; 6(11): e1001184 - Pubmed link
- Sotiropoulou, P. A. et al., Stem Cells, 2006; 24(1): 74-85. - Pubmed link
- Stebbing J. et al., Ann. Onc., 2003; 14(11): 1660 - 1666 - Pubmed link
- Stebbing, J. et al., Clin Exp Immunol.,2004; 138(2): 312-6. - Pubmed link
- Surbatovic, M. et al., Sci Rep.,2015;5:11355 - Pubmed link
- Taront, S. et al.,Part Fibre Toxicol.,2009;6:9 - Pubmed link
- Verdijk R M. et al., J. Immunol., 1999; 163(1): 57 - 61 - Pubmed link
- Hijazi,Y. et al.,Curr Clin Pharmacol. 2018;13(1):55-64. - Pubmed link
- Lopez-Abente, J. et al.,Cell Mol Immunol. 2018 Oct;15(10):917-933 - Pubmed link
- Madempudi, R.S. et al.,Sci Rep. 2019 Aug 21;9(1):12210. - Pubmed link
- Vazquez-Madrigal, C. et al., Nutrients. 2020 Oct; 12(10): 3139. - Pubmed link
- KÖŞger, F. et al., Noro Psikiyatr Ars. 2020 Dec; 57(4): 303–307. - Pubmed link
- Lima-Cabello, E. et al., Antioxidants (Basel) 2020 Jan; 9(1): 12. - Pubmed link
- Tuettenberg, A. et al., Exp Dermatol. 2007 Mar; 16(3): 171–178. - Pubmed link
- Divyapriya, D. et al., Postepy Dermatol Alergol. 2021 Oct; 38(5): 858–865. - Pubmed link
- Kowalewicz-Kulbat, M. et al., Vaccines (Basel) 2021 Mar; 9(3): 277. - Pubmed link
- Prat, M. et al., Cancers (Basel) 2021 Apr; 13(8): 1845. - Pubmed link
Related products
- 855.120.000 - Anti-Human IL-12 p35 Azide Free
- 855.130.000 - Anti-Human IL-12 p40 Azide Free
- 855.131.010 - Anti-Human IL-12 p40 FITC Conjugated
- 855.180.000 - Anti-Human IL-12 p40 Azide Free
- 879.070.001 - Anti-Human IL-12 p35 Capture (IL-12 p70 ELISA)
- 879.070.002 - Anti-Human IL-12 p40 Detection (IL-12 p70 ELISA)
- 879.075.001 - Anti-Human IL-12 p40 Capture (IL-12 p40 ELISA)
- 879.075.002 - Anti-Human IL-12 p40 Detection (IL-12 p40 ELISA)
- 660.040.096 - Murine IL-12 ELISA Kit
- 850.810.048 - Human IL-12p70 High Sensitivity ELISA Kit
- 950.075.048 - Human IL-12p40/p70 ELISA Kit
- 851.550.001 - Human IL-12p70 ELISA Set
- 856.081.001 - Human IL-12p70 ELISpot Set
- 856.081.001PC - Human IL-12p70 ELISpot Kit
- 869.040.010 - Human IL-12p70 ELISpot Pair
- 851.880.001 - Human IL-12p40/p70 ELISA Set
BACKGROUND
IL-12 is a potent regulator of cell mediated immune response produced by activated monocytes / macrophages cells, B lymphocytes and connective tissue type mast cells.
IL-12p70 is the biologically active form and is composed of two subunits: IL-12p35 (also named IL-12A) and IL-12p40 (also named IL-12B). The p35 subunit has homology to IL-6, while p40 has homology with IL-23. The p40 subunit has been found to be expressed in a higher excess over p70. It is present in serum and plasma as a monomer, as an heterodimer with IL-12p35 (biologically active IL-12p70) or a heterodimer with IL-23p19 (IL-23). The subunits are genetically unrelated and are regulated independently: IL-12p40 is produced constitutively and in excess of IL-12p35 and IL-23p19.
IL-12 has been found to bind to IL-12R. IL-12R has been reported to be present on IL-2 activated CD4+, CD8+ and CD56+ cells. IL-12 exerts a variety of biological effects on human T and NK cells. IL-12 induces an IFNg production and other cytokines from peripheral blood T and NK cells. Its role is directing development and proliferation of Th1 cells. Thus IL-12 is linked with autoimmunity, high level have also been reported for chronic inflammatory reactions, bacterial and viral infection.
IL-12 is a pleiotropic cytokine initially also called cytotoxic lymphocyte maturation factor (CLMF) or natural killer cell stimulatory factor (NKSF) mainly produced by monocytes, macrophages and dendritic cells in response to bacterial products or upon interaction with activated T Cell.
IL-12 induces IFNg production and increases proliferation and cytotoxic activity of T and NK cells. Moreover, IL-12 induces CD4+ polarization to the Th1 phenotype that mediates immunity against intracellular pathogens.
Several studies show that IL-12p40, in monomer or homodimer form, was able to bind to IL-12R beta-1 and seem to be antagonist to IL-12p70 and IL-23 bounding.
Version 19 - 05.22
For research use only
For any order, the purchaser acknowledges having read and accepted the terms and conditions described on the Diaclone website.